Summary:
For some children, teens, and adults with asthma, symptoms are not well controlled on current medications. These studies are researching an investigational medication for patients with uncontolled or severe asthma. The study drug is being tested to determine if it can reduce inflammation in patient's airways, improve asthma symptoms and decrease the number of asthma attacks. This trial is up to 64 weeks long, requiring up to 11 visits, up to 6 telephone visits, and no overnight stays.
Qualified Participants Must:
• Be 12 years of age or older
•
Have uncontrolled or severe asthma
Qualified Participants May Receive:
All study related medications and procedures will be provided